“REPAIR” system edits RNA, rather than DNA; has potential to treat diseases without permanently affecting the genome. The Broad Institute and MIT scientists who first harnessed CRISPR for mammalian genome editing have engineered a new molecular system for efficiently editing RNA in human cells. RNA editing, which can alter gene…

The following was adapted from a press release from the Cardiovascular Research Foundation. Elazer Edelman, the Thomas D. and Virginia W. Cabot Professor of Health Sciences at MIT, has been awarded this year’s Transcatheter Cardiovascular Therapeutics (TCT) Career Achievement Award ­for his extraordinary contributions to the field of cardiology. A lifelong researcher…

Once a year for two hours, a group of able-bodied students at the Massachusetts Institute of Technology take to the streets of Cambridge and their campus halls in wheelchairs, a news post by Alyssa Meyers recently published in the Boston Globe described. During another two-hour class period, they walk around the…

Study finds bacterial response to drugs varies in different environments. MIT and Harvard University researchers have engineered E. coli cells that can be used to study how bacteria at an infection site respond to antibiotic treatment, allowing scientists to learn more about how existing antibiotics work and potentially help them…

MEMP student Shriya Srinivasan, studying in the Harvard-MIT Health Sciences and Technology program (HST), the degree-granting educational arm of IMES, is featured in the September-October 2017 issue of Harvard Magazine for her work to improve the process for performing amputations. “Today’s state-of-the-art prosthetic limbs are scientific marvels, designed with robotics and sensors that…